The screening assay platform at Simbiosys
leverages our extensive range of biology and biochemistry
capabilities to offer a broad selection of therapeutic
target-based cell-based and biochemical assays. HTS
formats for most assays are available.
Simbiosys offers primary and secondary screening assays
against a portfolio of clinically validated and emerging
therapeutic targets for diabetes and obesity. We also
offer screening solutions using validated and emerging
cell model systems for targeted therapies against
Simbiosys is also developing specialized cell-based
in-vitro ADME assays starting with the Blood Brain
Barrier permeability assay.